Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - parvovirus suino, ceppo 27a, proteina virale 2 - immunologici per suidi - pigs - per l'immunizzazione attiva di scrofette e scrofe dall'età di 5 mesi per proteggere la prole contro transplacentare infezione causata dal parvovirus suino.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologici per aves - pollo - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - gatti - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. il medicinale veterinario è indicata esclusivamente quando tutti e tre i gruppi sono mirati al tempo stesso.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pollo - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - ciclesonide - sistema respiratorio, altri farmaci per le malattie respiratorie ostruttive, inalanti - cavalli - per la riduzione dei segni clinici di grave equina asma (precedentemente noto come ricorrenti di ostruzione delle vie aeree – (rao), pascolo estivo associato ricorrenti di ostruzione delle vie aeree – (spa-rao)).

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - ipratropii bromidum anhydricum - per inalazione inqua ® (dose unitaria) - ipratropii bromidum anhydricum 250 µg ut ipratropii bromidum, natrii chloridum corresp. natrium < 23 mg, acidum hydrochloridum, aqua purificata ad solutionem pro 2 ml. - bronchospasmolytikum - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - ipratropii bromidum anhydricum, salbutamolum - lösung für einen vernebler (einzeldosen) - ipratropii bromidum 0.52 mg corresp. ipratropii bromidum anhydricum 0.5 mg, salbutamoli sulfas 3.0 mg corresp. salbutamolum 2.5 mg, natrii chloridum, acidum hydrochloridum, aqua purificata, ad solutionem pro 2.5 ml. - bronchospasmolytikum - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - pramipexolum - compresse - pramipexoli dihydrochloridum monohydricum 0.125 mg corresp. pramipexolum 0.088 mg, mannitolum, maydis amylum, silica colloidalis anhydrica, povidonum k 25, magnesii stearas pro compresso. - il morbo di parkinson, trattamento sintomatico del idiopatica restless legs sindrome (rls) - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - pramipexolum - compresse - pramipexoli dihydrochloridum monohydricum 0.25 mg corresp. pramipexolum 0.18 mg, mannitolum, maydis amylum, silica colloidalis anhydrica, povidonum k 25, magnesii stearas pro compresso. - il morbo di parkinson, trattamento sintomatico del idiopatica restless legs sindrome (rls) - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - pramipexolum - compresse - pramipexoli dihydrochloridum monohydricum 1.00 mg corresp. pramipexolum 0.7 mg, mannitolum, maydis amylum, silica colloidalis anhydrica, povidonum k 25, magnesii stearas pro compresso. - il morbo di parkinson, trattamento sintomatico del idiopatica restless legs sindrome (rls) - synthetika